JP2008545700A5 - - Google Patents

Download PDF

Info

Publication number
JP2008545700A5
JP2008545700A5 JP2008513703A JP2008513703A JP2008545700A5 JP 2008545700 A5 JP2008545700 A5 JP 2008545700A5 JP 2008513703 A JP2008513703 A JP 2008513703A JP 2008513703 A JP2008513703 A JP 2008513703A JP 2008545700 A5 JP2008545700 A5 JP 2008545700A5
Authority
JP
Japan
Prior art keywords
group
ether
compound represented
atom
ether group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008513703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545700A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/020226 external-priority patent/WO2006127893A2/en
Publication of JP2008545700A publication Critical patent/JP2008545700A/ja
Publication of JP2008545700A5 publication Critical patent/JP2008545700A5/ja
Pending legal-status Critical Current

Links

JP2008513703A 2005-05-25 2006-05-25 ４−（ビフェニリル）アゼチジン−２−オンホスホン酸類の製造方法 Pending JP2008545700A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68448105P 2005-05-25 2005-05-25
PCT/US2006/020226 WO2006127893A2 (en) 2005-05-25 2006-05-25 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids

Publications (2)

Publication Number Publication Date
JP2008545700A JP2008545700A (ja) 2008-12-18
JP2008545700A5 true JP2008545700A5 (enExample) 2009-07-30

Family

ID=37103301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008513703A Pending JP2008545700A (ja) 2005-05-25 2006-05-25 ４−（ビフェニリル）アゼチジン−２−オンホスホン酸類の製造方法

Country Status (15)

Country Link
US (1) US20090099355A1 (enExample)
EP (1) EP1896135A2 (enExample)
JP (1) JP2008545700A (enExample)
KR (1) KR20080025077A (enExample)
CN (1) CN101222950A (enExample)
AU (1) AU2006249905A1 (enExample)
BR (1) BRPI0611415A2 (enExample)
CA (1) CA2609506A1 (enExample)
EA (1) EA200702614A1 (enExample)
IL (1) IL187626A0 (enExample)
MA (1) MA29553B1 (enExample)
NO (1) NO20076597L (enExample)
TW (1) TW200801027A (enExample)
WO (1) WO2006127893A2 (enExample)
ZA (1) ZA200710857B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
ATE369335T1 (de) * 2003-11-10 2007-08-15 Microbia Inc 4-biarylyl-1-phenylazetidin-2-one
SA04250427A (ar) 2003-12-23 2005-12-03 استرازينيكا ايه بي مشتقات ثاني فينيل أزيتيدون
US20060135755A1 (en) 2004-12-20 2006-06-22 Schering Corporation Process for the synthesis of azetidinones
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR057072A1 (es) 2005-06-22 2007-11-14 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
DE102005055726A1 (de) * 2005-11-23 2007-08-30 Sanofi-Aventis Deutschland Gmbh Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
AU2007283113A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
WO2008061238A2 (en) * 2006-11-16 2008-05-22 Ironwood Pharmaceuticals, Inc. Processes for production of 4-biphenylyazetidin-2-ones
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007063671A1 (de) 2007-11-13 2009-06-25 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
WO2009157019A2 (en) * 2008-06-23 2009-12-30 Ind-Swift Laboratories Limited Process for preparing ezetimibe using novel allyl intermediates
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
BR112012003973A2 (pt) 2009-08-26 2015-09-08 Sanofi Sa hidratos de fluoroglicosídeo heteroaromático cristalinos, produtos farmacêuticos compreendendo estes compostos e seu uso
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
CN102285932B (zh) * 2011-09-01 2013-06-12 浙江大学 一种依替米贝中间体的制备方法
CN104114562A (zh) * 2011-12-30 2014-10-22 陶氏益农公司 形成4-氯-2-氟-3-取代的苯基硼酸频哪醇酯的方法及其使用方法
CN103396429B (zh) * 2013-06-28 2016-05-25 杭州师范大学 一种硅手性中心的硅烷衍生物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67341A (en) * 1991-07-23 1995-03-28 Schering Corp Substituted beta-lactam compounds useful as hypocholesterolemic agents, pharmaceutical compositions containing the same and process for the production thereof
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
CA2158191A1 (en) * 1994-09-16 1996-03-17 Junji Yokoi Method for preventing settlement of aquatic fouling organisms
AR025144A1 (es) * 1998-12-07 2002-11-13 Schering Corp Proceso para preparar azetidinonas, proceso para preparar compuestos intermediarios asi como dichos compuestos intermediarios
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
HRP20030498A2 (en) * 2000-12-21 2005-04-30 Aventis Pharma Deutschland Gmbh Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
US6627757B2 (en) * 2001-03-28 2003-09-30 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
WO2004099132A2 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Process for the preparation of trans-isomers of diphenylazetidinone derivatives
ATE369335T1 (de) * 2003-11-10 2007-08-15 Microbia Inc 4-biarylyl-1-phenylazetidin-2-one
WO2006086562A2 (en) * 2005-02-09 2006-08-17 Microbia, Inc. Phenylazetidinone derivatives
TW200726746A (en) * 2005-05-06 2007-07-16 Microbia Inc Processes for production of 4-biphenylylazetidin-2-ones
BRPI0608970A2 (pt) * 2005-05-11 2010-02-17 Microbia Inc processos para produção de 4-bifenililazetidin-2-onas fenólicas

Similar Documents

Publication Publication Date Title
JP2008545700A5 (enExample)
JP2008540557A5 (enExample)
JP2004536811A5 (enExample)
JP2007524706A5 (enExample)
JP2013520495A5 (enExample)
RU2013114370A (ru) Производные эфиров фосфоновых кислот и способы их синтеза
JP2017210484A5 (enExample)
JP2004504323A5 (enExample)
JP5115477B2 (ja) 水酸基を有する３−エチルオキセタン化合物及びその製法
JP2011507941A5 (enExample)
JP2008526897A5 (enExample)
JP2008542205A5 (enExample)
JP2006514956A5 (enExample)
ES2295965T3 (es) Procedimiento para la obtencion de tolterodina.
JP5257353B2 (ja) 置換ヒドロキシメチルフェノールの新規な合成
JP2014520796A5 (enExample)
RU2007104036A (ru) Способ получения диизопропил (гидроксиметил)-циклопропил)окси) метилфосфоната
JP4018546B2 (ja) ３−（ｚ）−プロペニルセフェム化合物の選択的な製造方法
JP2008231223A (ja) 新規なオキセタン化ノボラック樹脂及びその製法
JP2002516895A (ja) 保護ジヒドロキシプロピルトリアルキルアンモニウム塩およびそれらの誘導体の調製方法
JP2007112723A (ja) アミノクロロヒドリン硫酸塩の製造方法
ES2522549T3 (es) Procedimiento para la preparación de 2-hidroxi-4-fenil-3,4-dihidro-2H-cromen-6-il-metanol y (R)-feso-deacilo
JP2004505073A (ja) 鎮咳活性を有する１，３−ジオキソラン
JP4518318B2 (ja) ベンゾ［ｃ］フェナンスリジン誘導体の新規製造法
JP3272340B2 (ja) １−［（シクロペント−３−エン−１−イル）メチル］−５−エチル−６−（３，５−ジメチルベンゾイル）−２，４−ピリミジンジオンの製造方法